Switch to:
More From Other Websites
NEURALSTEM, INC. Financials Aug 15 2014
NEURALSTEM, INC. Files SEC form 8-K, Results of Operations and Financial Condition Aug 08 2014
CUR: Neuralstem Pipeline Rolling Forward, Tackling Major Unmet Needs Aug 08 2014
Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update Aug 08 2014
NEURALSTEM, INC. Files SEC form 10-Q, Quarterly Report Aug 08 2014
NEURALSTEM, INC. Files SEC form 8-K, Other Events Aug 05 2014
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial Aug 04 2014
NEURALSTEM, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 30 2014
Neuralstem Added To Russell 3000 Index Jun 30 2014
Neuralstem, Inc. (CUR): NSI-189: What You Need To Know Jun 26 2014
An Early Valuation Of Neuralstem's NSI-189 For MDD Jun 26 2014
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder Jun 25 2014
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress Jun 19 2014
NEURALSTEM, INC. Files SEC form 8-K, Other Events Jun 18 2014
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical... Jun 18 2014
Neuralstem, Inc. – "The FDA is Not the Enemy" Jun 09 2014
Neuralstem, Inc. – "Most men would rather deny a hard truth than face it" May 28 2014
Neuralstem NSI-189 Abstract Teases At Potential Greatness May 28 2014
Neuralstem price target raised to $6 from $4.50 at Aegis May 27 2014
NEURALSTEM, INC. Files SEC form 8-K, Other Events May 23 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK